Back to User profile » Prof. Dr. Yoshiya Moriguchi
Papers published by Prof. Dr. Yoshiya Moriguchi:
Validation and Functional Relevance of the Short Form of the Perceived Deficits Questionnaire for Depression for Japanese Patients with Major Depressive Disorder [Corrigendum]
Sumiyoshi T, Uchida H, Watanabe K, Oosawa M, Ren H, Moriguchi Y, Fujikawa K, Fernandez J
Neuropsychiatric Disease and Treatment 2024, 20:491-492
Published Date: 6 March 2024
Goal Attainment Scaling for Depression: Validation of the Japanese GAS-D Tool in Patients with Major Depressive Disorder
Kato M, Kikuchi T, Watanabe K, Sumiyoshi T, Moriguchi Y, Oudin Åström D, Christensen MC
Neuropsychiatric Disease and Treatment 2024, 20:49-60
Published Date: 16 January 2024
Assessing Reliability and Validity of the Oxford Depression Questionnaire (ODQ) in a Japanese Clinical Population
Kato M, Kikuchi T, Watanabe K, Sumiyoshi T, Moriguchi Y, Åström DO, Christensen MC
Neuropsychiatric Disease and Treatment 2023, 19:2401-2412
Published Date: 8 November 2023
Validation and Functional Relevance of the Short Form of the Perceived Deficits Questionnaire for Depression for Japanese Patients with Major Depressive Disorder
Sumiyoshi T, Uchida H, Watanabe K, Oosawa M, Ren H, Moriguchi Y, Fujikawa K, Fernandez J
Neuropsychiatric Disease and Treatment 2022, 18:2507-2517
Published Date: 2 November 2022
Therapeutic Potential of Vortioxetine for Anhedonia-Like Symptoms in Depression: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan
Watanabe K, Fujimoto S, Marumoto T, Kitagawa T, Ishida K, Nakajima T, Moriguchi Y, Fujikawa K, Inoue T
Neuropsychiatric Disease and Treatment 2022, 18:363-373
Published Date: 19 February 2022
Therapeutic Potential of Vortioxetine for Anxious Depression: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan
Inoue T, Fujimoto S, Marumoto T, Kitagawa T, Ishida K, Nakajima T, Moriguchi Y, Fujikawa K, Watanabe K
Neuropsychiatric Disease and Treatment 2021, 17:3781-3790
Published Date: 21 December 2021
Early Improvement with Vortioxetine Predicts Response and Remission: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan
Inoue T, Fujimoto S, Marumoto T, Kitagawa T, Ishida K, Nakajima T, Moriguchi Y, Fujikawa K, Watanabe K
Neuropsychiatric Disease and Treatment 2021, 17:3735-3741
Published Date: 18 December 2021
Patient and Physician Perspectives of Depressive Symptoms and Expectations for Treatment Outcome: Results from a Web-Based Survey
Ishigooka J, Hoshino T, Imai T, Yoshida H, Ono M, Ota M, Moriguchi Y, Fujikawa K, Shintani A, Fernandez JL
Neuropsychiatric Disease and Treatment 2021, 17:2915-2924
Published Date: 10 September 2021
Relationship of Subjective Cognitive Impairment with Psychosocial Function and Relapse of Depressive Symptoms in Patients with Major Depressive Disorder: Analysis of Longitudinal Data from PERFORM-J
Sumiyoshi T, Watanabe K, Noto S, Sakamoto S, Moriguchi Y, Hammer-Helmich L, Fernandez J
Neuropsychiatric Disease and Treatment 2021, 17:945-955
Published Date: 26 March 2021